age
float64 18
102
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
| event_times
int64 3
2.03k
| event_indicators
int64 0
1
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
61.64798
|
female
| 0
| 8
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 12
|
$25-$50k
| 0
| 5,194
| 3,546.2168
| 4,267.53906
| 6
|
white
| 29.398438
| 53
| 0.743896
| 0.596924
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 8
| 109
| 4.199219
| 110
| 24
| 36.09375
| 285.6875
| 3.399902
| 0.799927
| 3.299805
| 129
| 7.509766
| null | null | null | null | null | null | 2.67041
| 1,328
| 0
|
73.68695
|
male
| 0
| 4
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 12
|
under $11k
| 0
| 4,337
| 2,941.3672
| 3,158.86914
| 15
|
white
| 17
| 12
| 0.85791
| 0.764893
| 1
| 0
| 0
|
no
| 0.8
| 0.75
|
no dnr
| 4
| 99
| 19
| 107
| 20
| 36.29688
| 210
| 4.099609
| 0.5
| 1.199951
| 140
| 7.429688
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.081543
| 1,323
| 0
|
70.51599
|
female
| 0
| 4
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 12
| null | 0
| 9,541
| 6,665.918
| 6,835.14844
| 33
|
white
| 35.398438
| 50
| 0.390991
| 0.271973
| 1
| 0
| 0
|
yes
| null | null |
dnr after sadm
| 1
| 99
| 62.195313
| 64
| 32
| 35.79688
| 100
| null | 10.699219
| 0.899902
| 137
| 7.449219
| null | null | null | null | null |
<2 mo. follow-up
| 2.220703
| 5
| 1
|
81.77399
|
male
| 0
| 25
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 14
| null | 0
| 82,252
| 58,002.0938
| 54,091.5625
| 24.75
|
white
| 26.898438
| 51
| 0.579956
| 0.469971
| 34
| 0
| 0
|
no
| null | null |
no dnr
| 25
| 58
| 21.398438
| 120
| 14
| 38.09375
| 257.125
| 2.599609
| 0.599976
| 2.399902
| 132
| 7.369141
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 163
| 1
|
64.05695
|
male
| 0
| 8
|
Lung Cancer
|
Cancer
| 1
| 10
| null | 0
| 8,466
| null | null | 17.5
|
white
| 35
| 25
| 0.228973
| 0.025997
| 1
| 0
| 0
|
metastatic
| 0.49
| 0.19
|
dnr after sadm
| 2
| 73
| 9.898438
| 110
| 24
| 35.69531
| 376
| 2.199707
| 0.5
| 0.899902
| 136
| 7.509766
| null | null | null | null | 6
|
<2 mo. follow-up
| 6
| 17
| 1
|
85.22095
|
female
| 0
| 3
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| null | null | 0
| 1,936
| 1,283.6807
| 1,240.06934
| 21
|
white
| 15.398438
| 16
| 0.773926
| 0.639893
| 1
| 0
| 0
|
yes
| 0.9
| 0.8
|
dnr after sadm
| 1
| 77
| 7.799805
| 73
| 20
| 35.79688
| 320
| 3.799805
| 0.599976
| 0.699951
| 135
| 7.429688
| null | null | null | null | null | null | 3.181152
| 290
| 1
|
68.75299
|
female
| 0
| 17
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 12,189
| 7,941.2812
| 7,425.61719
| 13
|
white
| 18.699219
| 21
| 0.861938
| 0.770996
| 1
| 1
| 0
|
no
| 0.8
| 0.5
|
no dnr
| 17
| 82
| null | 81
| 26
| 36.09375
| 196.28125
| 3.399902
| 0.799927
| 1
| 136
| 7.339844
| null | null | null | null | 1
|
no(M2 and SIP pres)
| 1
| 1,320
| 0
|
72.70599
|
male
| 0
| 21
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 7
|
$11-$25k
| 26
| 81,726
| 53,869.1562
| 52,721.875
| 21
|
white
| 30.296875
| 42
| 0.422974
| 0.303955
| 24
| 0
| 0
|
no
| null | null |
no dnr
| 21
| 80
| 11.099609
| 112
| 27
| 36.89844
| 93.32812
| null | null | 1.399902
| 138
| 7.509766
| null | null | null | null | 0
|
adl>=4 (>=5 if sur)
| 0
| 1,319
| 0
|
67.146
|
female
| 1
| 57
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| null | null | 26
| 184,437
| 121,788.375
| 132,234.75
| 35.5
|
white
| 20.398438
| 27
| 0.703979
| 0.61499
| 33
| 0
| 0
|
no
| 0.7
| 0.7
|
dnr after sadm
| 53
| 132
| 8.199219
| 150
| 8
| 39
| 315
| null | null | 0.599976
| 135
| 7.469727
| null | null | null | null | null |
<2 mo. follow-up
| 2.168945
| 57
| 1
|
67.30695
|
female
| 0
| 37
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 0
| 94,682
| 66,285.875
| 63,621.2812
| 28.75
|
white
| 29.796875
| 52
| 0.61792
| 0.512939
| 11
| 1
| 1
|
no
| null | null |
dnr after sadm
| 5
| 118
| 22.796875
| 120
| 26
| 36.59375
| 128.5625
| 2.799805
| 0.5
| 1.599854
| 141
| 7.25
| null | null | null | null | null |
<2 mo. follow-up
| 3.8125
| 39
| 1
|
79.90997
|
male
| 0
| 34
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 8
|
under $11k
| 9
| 28,112
| 19,613.2969
| 19,509.2656
| 17.5
|
white
| 17.097656
| 26
| 0.829956
| 0.772949
| 1
| 0
| 1
|
no
| 0.7
| 0.7
|
dnr after sadm
| 2
| 68
| 20.699219
| 78
| 22
| 36.69531
| null | null | null | 1
| 133
| null | null | null | null | null | 3
|
adl>=4 (>=5 if sur)
| 3
| 225
| 1
|
60.58899
|
female
| 0
| 47
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 14
|
under $11k
| 0
| 109,058
| 75,702.5
| 67,278.625
| 31
|
white
| 38.398438
| 68
| 0.405945
| 0.28595
| 24
| 1
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 47
| 51
| 22
| 135
| 35
| 36.79688
| 192
| 2.599609
| 1.099854
| 4.899414
| 135
| 7.429688
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,316
| 0
|
69.80194
|
male
| 0
| 13
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| 8
|
under $11k
| 0
| 10,474
| 7,049.2891
| 6,434.91797
| 11
|
white
| 23.898438
| 44
| 0.78894
| 0.661987
| 1
| 1
| 0
|
no
| 0.9
| 0.8
|
dnr after sadm
| 4
| 112
| null | 70
| 36
| 36
| 132
| null | null | 1.299805
| 137
| 7.299805
| null | null | null | null | null |
no(M2 and SIP pres)
| 3.908691
| 137
| 1
|
59.168
|
male
| 0
| 4
|
Lung Cancer
|
Cancer
| 1
| 19
|
$25-$50k
| 0
| 3,412
| 2,211.0644
| 2,123.4082
| 12
|
white
| 10.398438
| 16
| 0.826904
| 0.625
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 4
| 102
| 3.5
| 101
| 20
| 36.59375
| null | 4
| 0.5
| 1.199951
| 139
| null | null | null | null | null | null |
no(M2 and SIP pres)
| 1.807861
| 245
| 1
|
69.09796
|
male
| 0
| 22
|
Coma
|
Coma
| 0
| 8
| null | 26
| 23,301
| 34,290.9688
| 33,719
| 20
|
white
| 18.699219
| 38
| 0.670898
| 0.613892
| 1
| 0
| 0
|
no
| 0.75
| 0.5
|
dnr after sadm
| 1
| 107
| 8.898438
| 78
| 36
| 37.69531
| 305
| 2.899902
| 0.5
| 2.399902
| 141
| 7.40918
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,312
| 0
|
32.27399
|
female
| 0
| 37
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| null | null | 0
| 80,302
| 49,708.4688
| 52,119.3125
| 26.75
|
white
| 28.5
| 38
| 0.790894
| 0.7229
| 25
| 0
| 0
|
no
| 0.5
| 0.4
|
dnr after sadm
| 5
| 107
| 5.899414
| 126
| 40
| 38.89844
| 152.5
| 2.399902
| 0.799927
| 0.599976
| 138
| 7.469727
| null | null | null | null | null | null | 2.404785
| 124
| 1
|
78.21198
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 9
|
under $11k
| 0
| 3,987
| 2,706.4766
| 2,549.17969
| 6
|
white
| 18.796875
| 17
| 0.834961
| 0.72998
| 1
| 0
| 0
|
no
| 0.9
| 0.75
|
no dnr
| 7
| 82
| 11.099609
| 104
| 24
| 36.59375
| null | 3.199707
| 1.199951
| 1.199951
| 136
| null | null | null | null | 0
| null |
<2 mo. follow-up
| 0.4948
| 38
| 1
|
59.87698
|
male
| 0
| 6
|
Lung Cancer
|
Cancer
| 3
| 12
|
$11-$25k
| 9
| 4,064
| 2,535.625
| 2,750.60938
| 7
|
white
| 26.296875
| 31
| 0.450989
| 0.138977
| 1
| 0
| 0
|
metastatic
| 0.39
| 0.19
|
no dnr
| 6
| 65
| 0.899902
| 63
| 20
| 36.39844
| null | 2.699707
| 0.5
| 0.599976
| 135
| null | null | null | null | null | null |
adl>=4 (>=5 if sur)
| 2.790039
| 78
| 1
|
75.93195
|
male
| 0
| 21
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 6
|
under $11k
| 0
| 29,476
| 19,041.3281
| 12,825.5625
| 18.666656
|
white
| 21.898438
| 42
| 0.80188
| 0.679932
| 1
| 0
| 0
|
no
| 0.9
| 0.7
|
no dnr
| 21
| 63
| 5.099609
| 70
| 29
| 36.39844
| null | null | null | 2
| 131
| null | null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,059
| 1
|
68.05695
|
male
| 0
| 18
|
MOSF w/Malig
|
ARF/MOSF
| 3
| null | null | 26
| 25,959
| 18,683.5469
| 18,205.5312
| 27.333328
|
white
| 28.398438
| 45
| 0.468994
| 0.349976
| 1
| 1
| 0
|
yes
| null | null |
no dnr
| 18
| 57
| 100
| 105
| 12
| 38.39844
| 131.65625
| 3.099609
| 1.699951
| 1.399902
| 146
| 7.489258
| null | null | null | null | 0
|
no(M2 and SIP pres)
| 0
| 1,097
| 1
|
69.711
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 2
| 8
| null | 0
| 5,852
| 3,574.4023
| 3,378.56836
| 7
|
white
| 25.5
| 25
| 0.487
| 0.167999
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 5
| 108
| 5.799805
| 107
| 18
| 35.89844
| null | null | null | 1.299805
| 125
| null | null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,212
| 1
|
76.76898
|
female
| 1
| 12
|
Colon Cancer
|
Cancer
| 1
| 12
|
under $11k
| 0
| 7,139
| 4,815.7656
| 5,323.9375
| 15.5
|
white
| 25.097656
| 24
| 0.641968
| 0.332947
| 1
| 0
| 0
|
metastatic
| null | null |
dnr after sadm
| 1
| 75
| 14.298828
| 110
| 22
| 35.59375
| null | 3.199707
| 0.5
| 0.899902
| 136
| null | null | null | null | null | 7
|
<2 mo. follow-up
| 7
| 12
| 1
|
84.159
|
female
| 0
| 14
|
Coma
|
Coma
| 1
| 14
| null | 61
| 17,962
| 12,456.6641
| 12,592.9766
| 14
|
white
| 23.398438
| 41
| 0.172974
| 0.116989
| 4
| 0
| 0
|
no
| 0.25
| 0.1
|
no dnr
| 14
| 123
| 17.898438
| 150
| 36
| 38.19531
| null | null | null | 0.699951
| 136
| null | null | null | null | null | 0
|
<2 mo. follow-up
| 0
| 18
| 1
|
66.30798
|
male
| 0
| 3
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
| null | 0
| 2,328
| 1,629.7373
| 1,673.83984
| 24
|
white
| 21.097656
| 25
| 0.845947
| 0.747925
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 1
| 121
| 6.099609
| 68
| 24
| 35.29688
| 342.8125
| 3.399902
| 0.799927
| 1.799805
| 140
| 7.379883
| null | null | null | null | null |
no(M2 and SIP pres)
| 2.312988
| 1,302
| 0
|
62.58197
|
female
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
$11-$25k
| 0
| 8,455
| 6,367.9336
| 5,471.79688
| 11.5
|
white
| 23
| 21
| 0.827881
| 0.769897
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 9
| 91
| 12.398438
| 104
| 24
| 38.59375
| 140
| 3.099609
| 1.099854
| 0.899902
| 139
| 7.379883
| null | null | null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,305
| 0
|
66.13794
|
female
| 0
| 46
|
Coma
|
Coma
| 1
| 12
|
under $11k
| 41
| 132,609
| 94,985.75
| 91,633.4375
| 23.5
|
white
| 18.898438
| 30
| 0.515991
| 0.444946
| 27
| 0
| 0
|
no
| null | null |
no dnr
| 46
| 100
| null | 124
| 32
| 38
| null | null | null | null | 140
| null | null | null | null | null | 7
|
adl>=4 (>=5 if sur)
| 7
| 1,301
| 0
|
63.90097
|
male
| 1
| 4
|
Coma
|
Coma
| 1
| null | null | 100
| 4,364
| 3,167.4707
| 3,277.06836
| 25
| null | 25.597656
| 43
| 0.174988
| 0.117996
| 1
| 0
| 0
|
no
| 0.5
| 0.3
|
dnr after sadm
| 3
| 123
| 10.599609
| 152
| 42
| 38.19531
| 155
| 3.099609
| 1
| 1.099854
| 142
| 7.439453
| null | null | null | null | null |
<2 mo. follow-up
| 2.584473
| 4
| 1
|
62.98199
|
male
| 0
| 3
|
Lung Cancer
|
Cancer
| 1
| 14
|
$11-$25k
| 0
| 3,867
| 2,166.8477
| 1,386.05957
| 7
|
white
| 17.398438
| 18
| 0.703979
| 0.419983
| 1
| 0
| 0
|
metastatic
| 0.95
| 0.5
|
no dnr
| 3
| 117
| 2.799805
| 104
| 20
| 36.09375
| null | null | 0.299988
| 1.199951
| 139
| null | null | null | null | null | 3
|
no(M2 and SIP pres)
| 3
| 479
| 1
|
68.11798
|
female
| 0
| 38
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 8
|
$11-$25k
| 37
| 52,306
| 38,925.5625
| 31,323.5
| 21.5
|
white
| 24.898438
| 48
| 0.660889
| 0.562988
| 1
| 1
| 0
|
no
| 0.5
| 0.5
|
no dnr
| 38
| 103
| 8.5
| 108
| 10
| 38.5
| null | null | null | null | 140
| null | null | null | 3,140
| null | 5
|
adl>=4 (>=5 if sur)
| 5
| 1,089
| 0
|
50.47198
|
male
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 12
| null | 0
| 5,953
| 3,888.6113
| 2,592.92969
| 7.5
|
white
| 19.5
| 9
| 0.901978
| 0.834961
| 1
| 0
| 0
|
no
| 0.85
| 0.65
|
no dnr
| 7
| 66
| 9.5
| 106
| 26
| 36
| 393.75
| 3.799805
| 1.5
| 1.899902
| 134
| 7.519531
| 155
| 32
| 350
| 0
| 2
|
no(M2 and SIP pres)
| 2
| 647
| 1
|
42.72699
|
female
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 16
|
$25-$50k
| 0
| 62,248
| 40,416.125
| 42,746.7812
| 28.5
|
white
| 30
| 55
| 0.7229
| 0.637939
| 25
| 0
| 0
|
no
| 0.5
| 0.4
|
no dnr
| 13
| 68
| 10.898438
| 67
| 11
| 38.5
| 204
| 2.099609
| 1
| 5.5
| 137
| 7.469727
| 120
| 55
| 100
| null | 0
|
no(M2 and SIP pres)
| 0
| 1,088
| 0
|
65.11694
|
female
| 0
| 7
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 7
| null | 0
| 6,253
| 4,228.2773
| 3,942.03906
| 4
|
white
| 9
| 17
| 0.92688
| 0.875977
| 1
| 0
| 0
|
yes
| 0.6
| 0.3
|
dnr after sadm
| 5
| 77
| 8.199219
| 97
| 22
| 36.79688
| null | 4.099609
| 1
| 0.899902
| 142
| null | 120
| 13
| 400
| 1
| null |
no(M2 and SIP pres)
| 1.166748
| 172
| 1
|
87.461
|
female
| 0
| 21
|
CHF
|
COPD/CHF/Cirrhosis
| 2
| 8
|
under $11k
| 0
| 17,285
| 11,621.2344
| 9,995.19531
| 8.333328
|
white
| 13.599609
| 17
| 0.86499
| 0.775879
| 1
| 0
| 0
|
no
| 0.8
| 0.5
|
dnr after sadm
| 1
| 93
| 2.199707
| 60
| 20
| 36.19531
| null | 3.199707
| 2.099609
| 0.599976
| 138
| null | 103
| 13
| null | 0
| 3
|
<2 mo. follow-up
| 3
| 26
| 1
|
63.41998
|
male
| 0
| 12
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| null | null | 0
| 9,577
| 6,214.8398
| 6,211.10938
| 8
|
white
| 28.699219
| 51
| 0.755981
| 0.613892
| 1
| 0
| 0
|
no
| 0.7
| 0.4
|
no dnr
| 12
| 123
| 7.799805
| 79
| 32
| 35.09375
| 492
| 3.699707
| 1.099854
| 1.799805
| 135
| 7.439453
| 131
| 35
| 1,265
| null | null | null | 3.754395
| 72
| 1
|
69.24597
|
female
| 1
| 10
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 16
|
$25-$50k
| 0
| 17,546
| 11,843.5469
| 10,895.1953
| 18
|
white
| 23.398438
| 20
| 0.578979
| 0.468994
| 5
| 0
| 0
|
metastatic
| 0.5
| 0.4
|
dnr after sadm
| 9
| 126
| 27.5
| 109
| 26
| 35.89844
| 432
| 2.299805
| 1.199951
| 7.599609
| 131
| 7.339844
| 153
| 154
| 2,276
| null | 5
|
<2 mo. follow-up
| 5
| 10
| 1
|
63.83798
|
female
| 0
| 9
|
CHF
|
COPD/CHF/Cirrhosis
| 3
| 9
|
under $11k
| 0
| 5,725
| 3,879.4102
| 2,918.94922
| 8
|
white
| 18
| 18
| 0.883911
| 0.805908
| 1
| 1
| 0
|
no
| 0.75
| 0.75
|
no dnr
| 9
| 71
| 5.899414
| 76
| 16
| 36.69531
| null | 3.899902
| 0.899902
| 1.299805
| 134
| null | 86
| 16
| null | 0
| 1
|
no(M2 and SIP pres)
| 1
| 281
| 1
|
79.39795
|
male
| 0
| 10
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 12
|
$11-$25k
| 0
| 8,833
| 6,296.0547
| 5,471.19922
| 10.5
|
white
| 24.5
| 28
| 0.708984
| 0.54895
| 1
| 0
| 0
|
no
| 0.99
| 0.8
|
dnr before sadm
| -1
| 109
| 5.5
| 132
| 8
| 39.5
| 399.625
| 1.699951
| 1.599854
| 0.799927
| 148
| 7.359375
| 152
| 21
| 1,225
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,082
| 0
|
75.56995
|
female
| 1
| 39
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 16
|
$25-$50k
| 0
| 77,306
| 48,291.8438
| 50,790.875
| 23.75
|
white
| 23.597656
| 32
| 0.747925
| 0.668945
| 3
| 0
| 0
|
no
| 0.9
| 0.8
|
dnr after sadm
| 39
| 68
| 39.59375
| 68
| 24
| 36.09375
| null | 2.5
| 5.299805
| 2.399902
| 129
| null | 272
| 62
| 1,230
| null | 1
|
<2 mo. follow-up
| 1
| 39
| 1
|
34.65298
|
male
| 0
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
$25-$50k
| 44
| 29,222
| 20,343.5312
| 19,508.7969
| 15
|
white
| 24.898438
| 48
| 0.731934
| 0.647949
| 8
| 0
| 0
|
no
| null | null |
no dnr
| 12
| 115
| 4.5
| 60
| 12
| 36.59375
| 173.53125
| 2
| 1.199951
| 0.699951
| 142
| 7.549805
| 151
| 15
| 3,153
| null | 0
|
no(M2 and SIP pres)
| 0
| 1,081
| 0
|
74.57898
|
male
| 0
| 8
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 4,308
| 2,934.709
| 3,172.54883
| 6.5
|
white
| 13.398438
| 14
| 0.75293
| 0.495972
| 1
| 0
| 0
|
metastatic
| 0.75
| 0.5
|
dnr before sadm
| -1
| 111
| 6.799805
| 64
| 22
| 36.09375
| null | 3.199707
| 0.799927
| 1.899902
| 139
| null | 93
| 32
| 1,425
| null | null | null | 2.664063
| 567
| 1
|
72.97498
|
female
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 8
|
under $11k
| 0
| 8,002
| 5,365.7031
| 4,766.54688
| 12.5
|
white
| 22.796875
| 37
| 0.785889
| 0.656982
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 9
| 68
| 6.299805
| 113
| 28
| 37.19531
| 244.4375
| null | null | 1
| 137
| 7.359375
| 108
| 6
| 1,384
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,079
| 0
|
77.823
|
male
| 0
| 8
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 11
| null | 0
| 8,005
| 5,048.3125
| 4,429.75781
| 11.5
|
white
| 11.398438
| 32
| 0.893921
| 0.821899
| 1
| 0
| 0
|
no
| 0.9
| 0.75
|
no dnr
| 8
| 107
| 12.298828
| 96
| 32
| 35.69531
| null | 3.399902
| 0.799927
| 1
| 126
| null | 132
| 10
| 5,350
| 4
| 0
|
no(M2 and SIP pres)
| 0
| 776
| 1
|
77.5
|
female
| 1
| 4
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 8
| null | 0
| 16,565
| 10,627.6406
| 25,434.0156
| 48
|
white
| 36.195313
| 67
| 0.329956
| 0.214996
| 4
| 0
| 0
|
yes
| 0.09
| 0.09
|
dnr before sadm
| -3
| 149
| 6.299805
| 114
| 26
| 36.69531
| 190
| 2.099609
| 1.699951
| 4.5
| 141
| 7.469727
| 211
| 92
| 438
| null | 1
|
<2 mo. follow-up
| 1
| 4
| 1
|
64.18597
|
female
| 1
| 12
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 12
| null | 37
| 168,012
| 105,001
| 98,044
| 42.5
|
white
| 26.699219
| 50
| 0.510986
| 0.394958
| 95
| 0
| 0
|
no
| 0.05
| 0.03
|
dnr after sadm
| 4
| 131
| 16.597656
| 118
| 25
| 37.69531
| 206
| 3.399902
| 0.599976
| 2.799805
| 136
| 7.399414
| 180
| 33
| 1,327
| null | 6
|
<2 mo. follow-up
| 6
| 12
| 1
|
82.55396
|
female
| 1
| 4
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 1
| 8
|
under $11k
| 100
| 8,436
| 6,312.2773
| 6,558.98828
| 38
|
white
| 50.398438
| 100
| 0
| 0
| 1
| 0
| 0
|
no
| 0.2
| 0.02
|
dnr after sadm
| 4
| 67
| 14.699219
| 126
| 34
| 35.69531
| 183.3125
| 1.799805
| 0.799927
| 2.899902
| 138
| 7.369141
| 174
| 75
| 4,340
| null | null |
<2 mo. follow-up
| 3.834473
| 4
| 1
|
30.987
|
female
| 0
| 10
|
Cirrhosis
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$25-$50k
| 0
| 10,124
| 6,855.1562
| 6,209.31641
| 17
|
white
| 27.5
| 37
| 0.834961
| 0.72998
| 1
| 0
| 0
|
no
| 0.85
| 0.5
|
no dnr
| 10
| 132
| 20.898438
| 147
| 38
| 38.59375
| 84
| 2.5
| 2.299805
| 0.799927
| 138
| 7.519531
| 238
| 19
| 3,565
| null | 0
|
no(M2 and SIP pres)
| 0
| 1,075
| 0
|
74.508
|
male
| 0
| 4
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 12
|
$11-$25k
| 0
| 2,104
| 1,398.7158
| 1,200.2793
| 5
|
white
| 24.398438
| 37
| 0.691895
| 0.526978
| 1
| 0
| 0
|
yes
| 0.3
| 0.2
|
dnr after sadm
| 1
| 97
| 15.398438
| 116
| 32
| 37.09375
| 146.03125
| 2.5
| 1
| 0.899902
| 122
| 7.239258
| 107
| 17
| 1,250
| 1
| 0
|
no(M2 and SIP pres)
| 0
| 1,075
| 0
|
66.245
|
male
| 0
| 7
|
Colon Cancer
|
Cancer
| 1
| 10
|
$11-$25k
| 0
| 7,801
| 4,927.7969
| 4,473.71875
| 5.5
|
white
| 17.398438
| 23
| 0.80896
| 0.590942
| 1
| 0
| 0
|
metastatic
| 1
| 1
|
dnr after sadm
| 1
| 121
| 10.099609
| 80
| 28
| 36.09375
| 52.59375
| 3.399902
| 0.699951
| 0.899902
| 144
| 7.30957
| 134
| 4
| 3,630
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 146
| 1
|
66.80597
|
female
| 0
| 6
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 8
| null | 0
| 4,827
| 3,117.4648
| 2,889.98828
| 10
|
white
| 15.398438
| 21
| 0.898926
| 0.830933
| 1
| 0
| 0
|
no
| 0.8
| 0.7
|
no dnr
| 6
| 116
| 16.199219
| 139
| 10
| 35.89844
| 195.46875
| 2
| 2
| 1.199951
| 143
| 7.449219
| 296
| 47
| 3,455
| null | null |
no(M2 and SIP pres)
| 1.962891
| 1,071
| 0
|
61.43997
|
female
| 1
| 8
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 0
| 43,480
| 29,285.5938
| 29,039
| 24.5
|
white
| 32.695313
| 55
| 0.60791
| 0.501953
| 5
| 0
| 0
|
no
| 0.8
| 0.5
|
no dnr
| 8
| 63
| 21.699219
| 126
| 22
| 39.19531
| 166
| 1.399902
| 2.5
| 1
| 149
| 7.419922
| 108
| 15
| 2,063
| 0
| null |
<2 mo. follow-up
| 0.494751
| 8
| 1
|
37.54999
|
male
| 0
| 29
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 12
|
under $11k
| 0
| 40,796
| 29,316.4375
| 25,175.2812
| 9.75
|
white
| 28.898438
| 41
| 0.777954
| 0.705933
| 11
| 1
| 0
|
no
| 0.8
| 0.5
|
no dnr
| 29
| 70
| 7.399414
| 140
| 20
| 36.79688
| null | 4.299805
| 1.099854
| 1
| 136
| null | 107
| 7
| null | 5
| 5
|
adl>=4 (>=5 if sur)
| 5
| 1,070
| 0
|
52.88998
|
male
| 0
| 10
|
Coma
|
Coma
| 2
| 8
|
$11-$25k
| 94
| 20,327
| 13,971.5
| 13,850.3281
| 35
|
white
| 24.796875
| 39
| 0.334961
| 0.262939
| 1
| 1
| 0
|
no
| 0.1
| 0
|
dnr after sadm
| 4
| 75
| 4
| 74
| 20
| 37.79688
| null | 4
| 0.399963
| 0.899902
| 140
| null | 98
| 8
| null | null | 1
|
<2 mo. follow-up
| 1
| 12
| 1
|
41.862
|
female
| 0
| 18
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 26
| 63,260
| 44,163.5312
| 42,367.3125
| 22.333328
|
white
| 30.597656
| 45
| 0.660889
| 0.562988
| 5
| 0
| 0
|
no
| 0.5
| 0.3
|
no dnr
| 18
| 143
| 8
| 100
| 20
| 36.69531
| null | 4.199219
| 0.699951
| 1.399902
| 138
| null | 101
| 18
| null | null | null | null | 2.576172
| 60
| 1
|
73.68097
|
male
| 0
| 11
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 15
|
$11-$25k
| 0
| 9,157
| 6,739.75
| 5,840.60938
| 9
|
white
| 21.296875
| 38
| 0.817993
| 0.703979
| 1
| 1
| 1
|
no
| null | null |
no dnr
| 11
| 103
| 0.189972
| 85
| 24
| 35
| 326.1875
| 2.199707
| 0.399963
| 0.5
| 129
| 7.519531
| 200
| 7
| 1,200
| 2
| 6
|
SIP>=30
| 6
| 355
| 1
|
88.58899
|
male
| 0
| 5
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 3
| null | 0
| 2,930
| 2,039.8115
| 1,935.58984
| 6
|
white
| 20.699219
| 30
| 0.765991
| 0.628906
| 1
| 0
| 0
|
no
| null | null |
dnr after sadm
| 1
| 74
| 14.798828
| 52
| 30
| 37.59375
| 105
| 3.399902
| 2.899902
| 0.799927
| 131
| 7.449219
| 144
| 16
| 1,823
| null | null |
no(M2 and SIP pres)
| 3.377441
| 666
| 1
|
62.56
|
male
| 1
| 5
|
Coma
|
Coma
| 1
| 16
|
$25-$50k
| 100
| 7,629
| null | null | 21
|
white
| 18.398438
| 24
| 0.394958
| 0.320984
| 1
| 0
| 0
|
no
| 0.1
| 0
|
dnr after sadm
| 2
| 111
| 7
| 118
| 24
| 35.89844
| 212.5
| 3.699707
| 0.299988
| 1.599854
| 137
| 7.289062
| 122
| 48
| 2,650
| null | null |
<2 mo. follow-up
| 2.310547
| 5
| 1
|
67.82495
|
female
| 0
| 17
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| null | null | 37
| 20,390
| 14,021.3594
| 13,929.6172
| 24.666656
|
white
| 31.296875
| 63
| 0.5
| 0.382996
| 1
| 1
| 0
|
no
| 0.85
| 0.7
|
no dnr
| 17
| 71
| 10.298828
| 122
| 32
| 35.79688
| 409.5
| 3.799805
| 1.699951
| 0.799927
| 115
| 7.509766
| 217
| 19
| 5,620
| null | 0
|
no(M2 and SIP pres)
| 0
| 950
| 1
|
81.82599
|
female
| 1
| 6
|
MOSF w/Malig
|
ARF/MOSF
| 5
| null |
under $11k
| 0
| 9,599
| 6,960.7734
| 6,414.91797
| 34
|
white
| 21.5
| 48
| 0.723999
| 0.639893
| 1
| 0
| 1
|
yes
| 0
| 0
|
dnr after sadm
| 3
| 110
| 10.298828
| 80
| 22
| 36.59375
| null | 1.199951
| 1.899902
| 1.5
| 134
| null | 94
| 25
| null | null | null |
<2 mo. follow-up
| 4.682617
| 6
| 1
|
61.20697
|
female
| 1
| 14
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 12
|
under $11k
| 26
| 12,832
| 35,940.7188
| 48,020.25
| 30
|
hispanic
| 31.097656
| 53
| 0.532959
| 0.417969
| 5
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 7
| 79
| 5.899414
| 114
| 10
| 38
| 103.42188
| 2.199707
| 0.5
| 2.599609
| 143
| 7.449219
| 126
| 26
| 1,062
| null | null |
<2 mo. follow-up
| 2.608887
| 14
| 1
|
82.11395
|
female
| 0
| 16
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| 12
| null | 26
| 20,328
| 13,797.9531
| 13,497.3359
| 20
|
hispanic
| 14.798828
| 13
| 0.778931
| 0.646973
| 1
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 7
| 110
| 39
| 142
| 40
| 35.89844
| 75
| 1.199951
| 0.899902
| 1.099854
| 142
| 7.509766
| 101
| 16
| 4,175
| null | 0
|
no(M2 and SIP pres)
| 0
| 719
| 1
|
70.00696
|
male
| 1
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 12
|
under $11k
| 9
| 31,634
| 22,024.7656
| 22,053.9062
| 23
|
white
| 18.796875
| 20
| 0.792969
| 0.724976
| 9
| 0
| 0
|
no
| null | null |
no dnr
| 6
| 101
| 5.399414
| 104
| 20
| 36.69531
| 253.4375
| 2.699707
| 0.699951
| 1.299805
| 141
| 7.439453
| 97
| 16
| null | null | 0
|
<2 mo. follow-up
| 0
| 6
| 1
|
71.198
|
female
| 0
| 10
|
MOSF w/Malig
|
ARF/MOSF
| 3
| 12
|
under $11k
| 44
| 29,653
| 19,878.0469
| 20,414.4375
| 26
|
white
| 20
| 47
| 0.56189
| 0.449951
| 3
| 1
| 0
|
yes
| 0.95
| 0.65
|
dnr after sadm
| 5
| 97
| 10
| 66
| 20
| 36.19531
| 170.9375
| 3.699707
| 0.399963
| 1.099854
| 140
| 7.349609
| 118
| 10
| 4,250
| null | 1
|
<2 mo. follow-up
| 1
| 18
| 1
|
66.02899
|
male
| 0
| 5
|
COPD
|
COPD/CHF/Cirrhosis
| 3
| 12
|
$11-$25k
| 0
| 3,923
| 2,519.0059
| 3,061.56836
| 8
|
white
| 13.699219
| 10
| 0.890991
| 0.817993
| 1
| 0
| 0
|
yes
| 0.8
| 0.6
|
dnr after sadm
| 1
| 133
| 4.799805
| 73
| 24
| 35.79688
| 240
| 3.599609
| 0.899902
| 0.799927
| 132
| 7.40918
| 208
| 9
| 4,354
| 4
| 5
|
SIP>=30
| 5
| 93
| 1
|
66.086
|
female
| 0
| 12
|
MOSF w/Malig
|
ARF/MOSF
| 4
| null | null | 0
| 11,931
| 7,972.5547
| 9,124.96875
| 14
|
white
| 24.296875
| 41
| 0.689941
| 0.5979
| 1
| 0
| 0
|
yes
| 0.6
| 0.5
|
dnr after sadm
| 2
| 141
| 10.099609
| 138
| 47
| 38.69531
| 73
| 3.199707
| 0.699951
| 0.899902
| 135
| 7.369141
| 226
| 17
| 2,462
| null | null | null | 3.161133
| 305
| 1
|
47.76498
|
female
| 0
| 3
|
Lung Cancer
|
Cancer
| 2
| 12
|
$25-$50k
| 0
| 2,900
| 1,750.4297
| 872.52978
| null |
white
| 15.199219
| 11
| 0.776978
| 0.534912
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.5
|
no dnr
| 3
| 123
| 11.199219
| 96
| 20
| 36
| 303.3125
| 3.899902
| 0.699951
| 1.299805
| 133
| 7.489258
| 130
| 11
| null | null | null |
no(M2 and SIP pres)
| 2.127441
| 85
| 1
|
67.05298
|
male
| 0
| 19
|
MOSF w/Malig
|
ARF/MOSF
| 2
| 12
|
$11-$25k
| 0
| 66,940
| 41,353.8438
| 41,568.0625
| 26
|
white
| 26.699219
| 52
| 0.518921
| 0.402954
| 34
| 0
| 0
|
yes
| 0.5
| 0.25
|
no dnr
| 19
| 129
| 14.298828
| 128
| 24
| 36.39844
| 430.6875
| 2.299805
| 1.199951
| 0.799927
| 129
| 7.519531
| 96
| 24
| 1,310
| 2
| 0
|
<2 mo. follow-up
| 0
| 57
| 1
|
56.41299
|
female
| 0
| 16
|
Colon Cancer
|
Cancer
| 2
| 12
|
$25-$50k
| 0
| 16,094
| 10,771.8047
| 10,005.0859
| 15.666664
|
white
| 23.597656
| 9
| 0.730957
| 0.460999
| 1
| 0
| 0
|
metastatic
| 0.9
| 0.7
|
no dnr
| 16
| 68
| 14.699219
| 60
| 32
| 36.29688
| 501.625
| 3.599609
| 1.199951
| 0.599976
| 132
| 7.449219
| 125
| 20
| 1,766
| 1
| 0
|
no(M2 and SIP pres)
| 0
| 417
| 1
|
56.67398
|
female
| 0
| 3
|
Lung Cancer
|
Cancer
| 1
| 14
| null | 26
| 9,091
| 6,717.8398
| 7,551.20703
| null |
white
| 20.097656
| 17
| 0.552979
| 0.22998
| 1
| 0
| 0
|
metastatic
| 0
| 0
|
dnr after sadm
| 1
| 60
| 20.296875
| 106
| 24
| 36.39844
| 191.40625
| 2.099609
| 0.599976
| 5.5
| 147
| 7.349609
| 143
| 113
| 1,015
| null | null |
<2 mo. follow-up
| 2.379883
| 56
| 1
|
64.84094
|
male
| 0
| 13
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 3
| 8
| null | 0
| 25,119
| 16,538.7188
| 15,737.1641
| 29.5
|
white
| 30.597656
| 42
| 0.658936
| 0.560913
| 3
| 1
| 0
|
no
| 0.85
| 0.5
|
no dnr
| 13
| 118
| 9.5
| 76
| 10
| 36.39844
| 178.5625
| 3.699707
| 0.599976
| 2.299805
| 142
| 7.219727
| 173
| 61
| 4,335
| null | 0
|
no(M2 and SIP pres)
| 0
| 1,054
| 0
|
62.20099
|
male
| 0
| 9
|
Lung Cancer
|
Cancer
| 3
| 8
|
$25-$50k
| 0
| 6,164
| 4,395.6094
| 4,622.83984
| 4
|
white
| 25.5
| 27
| 0.511963
| 0.189972
| 1
| 1
| 0
|
metastatic
| 0.25
| 0.05
|
dnr after sadm
| 6
| 101
| 14.099609
| 63
| 38
| 36.5
| 171.40625
| 3.199707
| 0.899902
| 1.099854
| 130
| 7.469727
| 156
| 37
| 3,945
| null | 4
|
<2 mo. follow-up
| 4
| 28
| 1
|
76.04095
|
male
| 1
| 3
|
Coma
|
Coma
| 1
| 8
|
$11-$25k
| 100
| 8,063
| 5,650.8984
| 5,565.87891
| 19
|
white
| 26.5
| 38
| 0.042999
| 0.021999
| 4
| 0
| 0
|
no
| null | null |
dnr after sadm
| 2
| 75
| 4
| 80
| 22
| 36.29688
| 376.625
| null | null | 1.199951
| 139
| 7.549805
| 24
| 18
| null | null | null |
<2 mo. follow-up
| 2.719727
| 3
| 1
|
75.79999
|
female
| 0
| 7
|
CHF
|
COPD/CHF/Cirrhosis
| 6
| 7
| null | 0
| 4,941
| 3,309.6856
| 2,727.34961
| 6.5
|
white
| 15.798828
| 13
| 0.875
| 0.791992
| 1
| 1
| 0
|
no
| 0.85
| 0.75
|
no dnr
| 7
| 74
| 23.5
| 81
| 24
| 36.09375
| 174.28125
| 3.599609
| 0.299988
| 0.799927
| 140
| 7.419922
| 125
| 9
| 1,710
| 1
| 0
|
no(M2 and SIP pres)
| 0
| 1,052
| 0
|
63.93997
|
female
| 0
| 56
|
Coma
|
Coma
| 1
| 14
|
$11-$25k
| 100
| 90,996
| 63,028.9375
| 67,949.75
| 33.25
|
white
| 23.398438
| 24
| 0.098999
| 0.058998
| 6
| 0
| 0
|
yes
| 0.8
| 0.7
|
no dnr
| 56
| 66
| 12
| 118
| 22
| 38.5
| 145.09375
| 2.599609
| 0.5
| 2.599609
| 149
| 7.40918
| 149
| 53
| 2,745
| null | 0
|
adl>=4 (>=5 if sur)
| 0
| 1,052
| 0
|
70.70197
|
male
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| null | null | 0
| 2,796
| 1,861.1143
| 1,850.37988
| 10
|
white
| 23.199219
| 15
| 0.545898
| 0.223999
| 1
| 0
| 0
|
metastatic
| 0.8
| 0.4
|
no dnr
| 5
| 58
| 24.5
| 153
| 18
| 39
| 47.19531
| 1.799805
| 1.099854
| 0.699951
| 145
| 7.349609
| 241
| 15
| 5,812
| null | null | null | 2.217773
| 67
| 1
|
74.43896
|
male
| 1
| 11
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 16
| null | 26
| 45,006
| 29,696.6562
| 64,308.4062
| 36
|
white
| 20.199219
| 16
| 0.714966
| 0.628906
| 5
| 0
| 0
|
no
| 0.5
| 0.5
|
dnr after sadm
| 11
| 91
| 7.899414
| 72
| 20
| 37.59375
| null | 2.699707
| 1.799805
| 0.699951
| 132
| null | 118
| 6
| 525
| null | 0
|
<2 mo. follow-up
| 0
| 11
| 1
|
76.59698
|
female
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 12
| null | 0
| 2,698
| 1,880.1592
| 2,167.23828
| 6
|
white
| 19
| 19
| 0.634888
| 0.323975
| 1
| 0
| 0
|
metastatic
| 0.4
| 0.05
|
dnr after sadm
| 3
| 122
| 5.399414
| 120
| 28
| 36.59375
| 206.4375
| 3.599609
| 0.199982
| 0.799927
| 139
| 7.289062
| 129
| 10
| 1,905
| null | null |
<2 mo. follow-up
| 2.238281
| 19
| 1
|
72.44598
|
male
| 0
| 6
|
CHF
|
COPD/CHF/Cirrhosis
| 6
| 3
|
under $11k
| 0
| 4,549
| 3,150.8008
| 2,777.62891
| 12
|
white
| 19.597656
| 12
| 0.842896
| 0.74292
| 1
| 1
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 6
| 115
| 10.398438
| 75
| 10
| 36
| 203.125
| 1.899902
| 2
| 0.699951
| 127
| 7.459961
| 152
| 11
| 1,970
| null | 0
|
no(M2 and SIP pres)
| 0
| 1,049
| 0
|
79.409
|
male
| 1
| 23
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 5
| 8
| null | 0
| 27,343
| 18,724.5156
| 16,082.6875
| 11.666664
|
white
| 25.296875
| 38
| 0.72998
| 0.645996
| 1
| 1
| 0
|
no
| null | null |
no dnr
| 23
| 109
| 13.5
| 54
| 24
| 38.39844
| 382.8125
| 2.5
| 0.399963
| 0.799927
| 139
| 7.5
| 116
| 11
| 2,835
| null | 2
|
<2 mo. follow-up
| 2
| 23
| 1
|
75.46899
|
female
| 0
| 6
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| null | null | 0
| 6,738
| 4,597.5352
| 4,253.64844
| 22
|
white
| 26.199219
| 48
| 0.731934
| 0.647949
| 1
| 0
| 0
|
no
| 0.95
| 0.8
|
no dnr
| 6
| 103
| 11.5
| 113
| 22
| 37.19531
| 168.5625
| 2.399902
| 0.899902
| 0.799927
| 138
| 7.299805
| 183
| 28
| null | null | null | null | 1.895508
| 1,048
| 0
|
70.00098
|
female
| 1
| 5
|
MOSF w/Malig
|
ARF/MOSF
| 1
| 12
|
$11-$25k
| 55
| 16,813
| 11,912.1953
| 12,922.0938
| 29
|
white
| 39.796875
| 70
| 0.034996
| 0.009998
| 3
| 0
| 0
|
yes
| 0.3
| 0.2
|
dnr after sadm
| 4
| 111
| 12.298828
| 131
| 28
| 36.69531
| 275
| 2.5
| 1.599854
| 0.899902
| 138
| 7.55957
| 109
| 11
| 1,340
| null | 3
|
<2 mo. follow-up
| 3
| 5
| 1
|
64.862
|
female
| 0
| 5
|
Lung Cancer
|
Cancer
| 1
| 12
| null | 0
| 3,304
| 2,222.3672
| 1,903.83984
| 6
|
white
| 15.798828
| 9
| 0.730957
| 0.460999
| 1
| 0
| 0
|
metastatic
| null | null |
no dnr
| 5
| 111
| 6.599609
| 75
| 16
| 35.79688
| null | null | null | 2.299805
| 139
| null | 301
| 40
| 1,420
| null | null | null | 1.982178
| 1,046
| 0
|
66.06396
|
male
| 0
| 8
|
Colon Cancer
|
Cancer
| 3
| 8
|
under $11k
| 0
| 4,612
| 3,072.0527
| 3,026.32812
| 8.5
|
white
| 24.398438
| 5
| 0.689941
| 0.397949
| 1
| 1
| 0
|
metastatic
| 0.7
| 0.4
|
no dnr
| 8
| 101
| 13.699219
| 61
| 24
| 36.29688
| 473.75
| null | null | 0.899902
| 130
| 7.449219
| 125
| 19
| 2,240
| null | 1
|
no(M2 and SIP pres)
| 1
| 1,045
| 0
|
80.70599
|
male
| 0
| 7
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 2
| 8
|
$11-$25k
| 0
| 15,582
| 10,023.0312
| 10,013.4453
| 9.5
|
white
| 23.296875
| 28
| 0.671997
| 0.576904
| 3
| 0
| 0
|
yes
| 0.98
| 0.9
|
no dnr
| 7
| 63
| 24.796875
| 56
| 36
| 35.5
| null | 2.699707
| 1.099854
| 2
| 132
| null | 181
| 90
| 6,176
| 0
| null | null | 0.494751
| 1,044
| 0
|
20.15599
|
male
| 0
| 26
|
Coma
|
Coma
| 0
| 14
|
under $11k
| 26
| 66,661
| 43,215.5625
| 44,197.5
| 21
|
white
| 35.898438
| 54
| 0.668945
| 0.611938
| 1
| 0
| 0
|
no
| 0.75
| 0.9
|
no dnr
| 26
| 122
| 6.899414
| 62
| 12
| 37.59375
| 244
| 2.899902
| 1.099854
| 1.599854
| 145
| 7.519531
| 135
| 31
| 3,052
| null | 0
|
no(M2 and SIP pres)
| 0
| 1,044
| 0
|
65.68896
|
male
| 0
| 6
|
Lung Cancer
|
Cancer
| 2
| 14
|
$11-$25k
| 0
| 3,969
| 2,548.1445
| 2,030.70996
| 4
|
white
| 20.898438
| 12
| 0.621948
| 0.307983
| 1
| 1
| 0
|
metastatic
| 0.3
| 0.1
|
no dnr
| 6
| 81
| 4.899414
| 55
| 24
| 36.29688
| null | 3.299805
| 0.899902
| 2
| 137
| null | 88
| 31
| 1,500
| 3
| 0
|
<2 mo. follow-up
| 0
| 44
| 1
|
79.09094
|
male
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 1
| null | null | 0
| 6,378
| 4,197.3984
| 5,589.23828
| 6.5
|
white
| 16.296875
| 26
| 0.838989
| 0.735962
| 1
| 0
| 0
|
no
| 0.9
| 0.9
|
no dnr
| 9
| 115
| 9.398438
| 91
| 20
| 36.5
| null | 3.699707
| 0.399963
| 1.5
| 133
| null | 142
| 10
| 6,275
| null | null | null | 3.007813
| 926
| 1
|
75.87695
|
female
| 1
| 20
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 8
|
under $11k
| 0
| 86,926
| 56,362.8438
| 54,649.0938
| 26
|
white
| 24.199219
| 52
| 0.677979
| 0.583984
| 30
| 0
| 0
|
no
| 0.1
| 0.6
|
no dnr
| 20
| 33
| 13.699219
| 161
| 10
| 37.5
| 90.54688
| 1.5
| 1.399902
| 2.899902
| 138
| 7.369141
| 233
| 62
| 75
| null | 1
|
<2 mo. follow-up
| 1
| 20
| 1
|
77.29498
|
male
| 1
| 36
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 0
| 8
| null | 0
| 89,062
| 58,730.5312
| 57,205.2188
| 30
|
white
| 25.398438
| 39
| 0.648926
| 0.54895
| 24
| 0
| 0
|
no
| 0.8
| 0.8
|
dnr after sadm
| 36
| 82
| 6.199219
| 96
| 24
| 36.79688
| 140.90625
| 3.899902
| 1.599854
| 1.099854
| 142
| 7.419922
| 153
| 13
| 750
| null | 1
|
<2 mo. follow-up
| 1
| 36
| 1
|
66.75397
|
male
| 0
| 16
|
CHF
|
COPD/CHF/Cirrhosis
| 4
| 15
|
$25-$50k
| 0
| 14,292
| 10,103.7656
| 8,128.36719
| 16
|
white
| 20
| 35
| 0.856934
| 0.763916
| 1
| 0
| 0
|
no
| null | null |
no dnr
| 16
| 115
| 8.898438
| 126
| 40
| 38.89844
| 377.5
| 2.5
| 0.699951
| 1.799805
| 144
| 7.469727
| 191
| 52
| 2,915
| 1
| 6
|
<2 mo. follow-up
| 6
| 31
| 1
|
75.79498
|
male
| 0
| 10
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 6
| 8
| null | 26
| 34,789
| 23,674.0156
| 23,985.4062
| 31.5
|
white
| 23.398438
| 50
| 0.552979
| 0.439941
| 7
| 1
| 0
|
yes
| 0.3
| 0.2
|
dnr after sadm
| 9
| 103
| 11.298828
| 68
| 20
| 37
| 295.1875
| 3.599609
| 0.699951
| 0.899902
| 139
| 7.459961
| 181
| 14
| null | null | 1
|
<2 mo. follow-up
| 1
| 15
| 1
|
70.76495
|
male
| 0
| 14
|
Coma
|
Coma
| 5
| 12
|
$11-$25k
| 41
| 11,963
| 8,354.4531
| 8,452.02344
| 11
|
white
| 24.796875
| 34
| 0.426941
| 0.352966
| 1
| 1
| 1
|
no
| 0.3
| 0.3
|
dnr before sadm
| -1
| 121
| 27.398438
| 120
| 50
| 38.89844
| 235.6875
| 2
| 2.699707
| 1.099854
| 143
| 7.549805
| 115
| 16
| 2,742
| null | 4
|
<2 mo. follow-up
| 4
| 19
| 1
|
78.67798
|
male
| 0
| 11
|
CHF
|
COPD/CHF/Cirrhosis
| 5
| 8
|
under $11k
| 0
| 17,143
| 11,050.6875
| 11,172.0391
| 8
|
white
| 16.296875
| 25
| 0.860962
| 0.770996
| 1
| 0
| 0
|
no
| 0.95
| 0.6
|
no dnr
| 11
| 58
| 17.097656
| 53
| 24
| 36.39844
| null | null | null | 0.299988
| 125
| null | 88
| 8
| 1,480
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,038
| 0
|
68.97998
|
male
| 0
| 12
|
Lung Cancer
|
Cancer
| 1
| 11
|
$11-$25k
| 0
| 6,820
| 4,525.5234
| 4,129.03906
| 3.5
|
white
| 13.699219
| 2
| 0.759888
| 0.505981
| 1
| 0
| 0
|
metastatic
| 1
| 1
|
no dnr
| 12
| 51
| 18.597656
| 112
| 16
| 38
| 84.53125
| 2
| 1.099854
| 1.099854
| 143
| 7.459961
| 123
| 18
| 1,915
| null | null |
no(M2 and SIP pres)
| 1.920166
| 96
| 1
|
40.86798
|
female
| 0
| 4
|
CHF
|
COPD/CHF/Cirrhosis
| 1
| 12
|
$11-$25k
| 0
| 3,969
| 2,673.0996
| 2,444.41992
| 10
|
white
| 9.398438
| 21
| 0.963989
| 0.937988
| 1
| 0
| 0
|
no
| 0.95
| 0.9
|
no dnr
| 4
| 50
| 18.699219
| 109
| 8
| 35.5
| 256.3125
| 1.699951
| 9
| 4.799805
| 141
| 7.399414
| 221
| 57
| 0
| null | null |
no(M2 and SIP pres)
| 1.506104
| 1,036
| 0
|
77.28998
|
male
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 11
|
$11-$25k
| 0
| 6,355
| 4,204.3125
| 4,802.33984
| 6.5
|
white
| 15.199219
| 12
| 0.859985
| 0.767944
| 1
| 0
| 0
|
no
| 0.9
| 0.5
|
no dnr
| 9
| 99
| 13.199219
| 100
| 24
| 35.79688
| 165.21875
| 3.299805
| 1.699951
| 0.699951
| 140
| 7.399414
| 128
| 10
| null | 0
| 0
|
no(M2 and SIP pres)
| 0
| 959
| 1
|
58.34399
|
male
| 0
| 28
|
Lung Cancer
|
Cancer
| 2
| null | null | 26
| 48,555
| 31,352.5781
| 28,168.9531
| 25.5
|
white
| 24.097656
| 31
| 0.432983
| 0.125977
| 1
| 0
| 0
|
metastatic
| 0.4
| 0.1
|
no dnr
| 28
| 105
| 11.798828
| 78
| 16
| 36
| 302.8125
| 4.199219
| 0.699951
| 1.399902
| 126
| 7.399414
| 79
| 15
| 2,800
| null | null | null | 2.901367
| 120
| 1
|
69.50299
|
male
| 0
| 9
|
ARF/MOSF w/Sepsis
|
ARF/MOSF
| 1
| 8
|
$11-$25k
| 0
| 19,367
| 12,622.4766
| 12,488.125
| 14.5
|
white
| 33
| 40
| 0.590942
| 0.482971
| 2
| 0
| 0
|
no
| 0.99
| 0.99
|
no dnr
| 9
| 107
| 11.599609
| 70
| 24
| 36.19531
| 284.25
| 3.699707
| 1
| 1.399902
| 145
| 7.40918
| 75
| 48
| 2,350
| 0
| 0
|
no(M2 and SIP pres)
| 0
| 1,034
| 0
|
77.13098
|
male
| 0
| 28
|
Coma
|
Coma
| 1
| 13
|
$25-$50k
| 89
| 37,480
| 25,343.3125
| 23,766.6719
| 22.75
|
white
| 14.5
| 21
| 0.299988
| 0.228973
| 2
| 0
| 0
|
yes
| 0.5
| 0.5
|
no dnr
| 28
| 127
| 7.899414
| 79
| 24
| 35.09375
| 266.625
| 3.599609
| 0.899902
| 2.299805
| 138
| 7.369141
| 207
| 27
| 3,055
| null | 0
|
adl>=4 (>=5 if sur)
| 0
| 1,034
| 0
|
80.66498
|
female
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 4
| 12
|
$11-$25k
| 0
| 7,578
| 5,084.1562
| 4,947.25781
| 12
|
white
| 16.699219
| 15
| 0.825928
| 0.716919
| 1
| 0
| 0
|
no
| 0.9
| 0.5
|
dnr before sadm
| -1
| 112
| 3
| 104
| 16
| 36.29688
| null | 2.899902
| 4.899414
| 0.599976
| 137
| null | 90
| 9
| null | 1
| 0
|
no(M2 and SIP pres)
| 0
| 1,033
| 0
|
64.03595
|
male
| 0
| 9
|
COPD
|
COPD/CHF/Cirrhosis
| 2
| 8
|
under $11k
| 0
| 6,096
| 4,047.0644
| 4,707.76953
| 7.5
|
white
| 16.398438
| 22
| 0.899902
| 0.832886
| 1
| 0
| 0
|
no
| 0.7
| 0.6
|
dnr after sadm
| 1
| 102
| 8.398438
| 78
| 24
| 37.89844
| null | 3
| 1.599854
| 1
| 133
| null | 101
| 9
| 3,650
| null | 0
|
<2 mo. follow-up
| 0
| 22
| 1
|
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.